| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 2,677 | 3,312 | 2,496 | 2,841 | | Cost of Revenue | 2,209 | 2,118 | 1,963 | 2,065 | | | Gross Profit | 468 | 1,194 | 533 | 776 | | | Operating Expenses | | Research Development | 1,053 | 1,365 | 1,346 | 1,300 | | Selling General and Administrative | 1,303 | 1,640 | 1,527 | 1,597 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 48 | 59 | 58 | 47 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,936) | (1,870) | (2,398) | (2,168) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,305 | (7,126) | 2,796 | (3,090) | | Earnings Before Interest And Taxes | 4,369 | (8,996) | 398 | (5,258) | | Interest Expense | 1,335 | 894 | 596 | 518 | | Income Before Tax | 3,034 | (9,890) | (198) | (5,776) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,034 | (9,890) | (198) | (5,776) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,034 | (9,890) | (198) | (5,776) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,034 | ($9,890) | ($198) | ($5,776) |
|
0.02% Nasdaq 0.00%
Income Statement
